New therapeutic avenues in ulcerative colitis: thinking out of the box
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New therapeutic avenues in ulcerative colitis: thinking out of the box
Authors
Keywords
-
Journal
GUT
Volume 62, Issue 11, Pages 1642-1652
Publisher
BMJ
Online
2013-10-09
DOI
10.1136/gutjnl-2012-303959
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Natural History of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis after Liver Transplantation – a Single-Centre Experience
- (2016) Karli J Moncrief et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- 943b Induction Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial
- (2015) B.G. Feagan et al. GASTROENTEROLOGY
- Su1934 First Reported Complication of Fecal Microbiota Transplant: Ulcerative Colitis Flare After FMT for Relapsing Clostridium difficile Infection
- (2015) James B. Watson et al. GASTROENTEROLOGY
- Tu1940 Cigarette Smoke Improves Selectively Colon and Not Small Bowel Inflammation Through NKT Cell Activation
- (2015) Muriel Montbarbon et al. GASTROENTEROLOGY
- 1157 Modified Release Phosphatidylcholine LT-02 in Active Ulcerative Colitis - a Randomized, Placebo-Controlled Multicentre Study
- (2015) Max Karner et al. GASTROENTEROLOGY
- Colonization with Heligmosomoides polygyrus Suppresses Mucosal IL-17 Production
- (2014) D. E. Elliott et al. JOURNAL OF IMMUNOLOGY
- Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission
- (2013) Mirjana Rajilić-Stojanović et al. INFLAMMATORY BOWEL DISEASES
- P323 Sustained therapeutic benefit of vedolizumab throughout 1 year in ulcerative colitis in GEMINI I, a randomized, placebo-controlled, double-blind, multicenter trial
- (2013) W. Sandborn et al. Journal of Crohns & Colitis
- P513 Efficacy of vedolizumab in ulcerative colitis by prior treatment failure in GEMINI I, a randomised, placebo-controlled, double-blind, multi-centre trial
- (2013) B. Feagan et al. Journal of Crohns & Colitis
- Fecal Microbiota Transplantation — An Old Therapy Comes of Age
- (2013) Ciarán P. Kelly NEW ENGLAND JOURNAL OF MEDICINE
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreasing Colectomy Rates for Ulcerative Colitis: A Population-Based Time Trend Study
- (2012) Gilaad G Kaplan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis
- (2012) William J Sandborn et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Therapeutic potential of human elafin: Figure 1
- (2012) Lee Shaw et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need for Colectomy in Patients With Ulcerative Colitis
- (2012) Udayakumar Navaneethan et al. Clinical Gastroenterology and Hepatology
- Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010
- (2012) Tine Jess et al. Clinical Gastroenterology and Hepatology
- Direct Health Care Insurer and Out-of-Pocket Expenditures of Inflammatory Bowel Disease: Evidence from a US National Survey
- (2012) Candace Gunnarsson et al. DIGESTIVE DISEASES AND SCIENCES
- Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
- (2012) Alison Ribeiro et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
- (2012) Henri Duboc et al. GUT
- Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated
- (2012) Elsenoor J. Klaver et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis
- (2012) Emma Calabrese et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Risk of Tuberculosis Reactivation With Tofacitinib (CP-690550)
- (2012) Mamoudou Maiga et al. JOURNAL OF INFECTIOUS DISEASES
- Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
- (2012) Céline Pirat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Elafin—a potential IBD therapy
- (2012) Claire Greenhill Nature Reviews Gastroenterology & Hepatology
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis
- (2012) J.-P. Motta et al. Science Translational Medicine
- Activity of Ulcerative Colitis Before and After Liver Transplantation in Primary Sclerosing Cholangitis: The Hungarian Experience
- (2012) F. Gelley et al. TRANSPLANTATION PROCEEDINGS
- Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases
- (2012) Madharasi VA Pichai WORLD JOURNAL OF GASTROENTEROLOGY
- The function of our microbiota: who is out there and what do they do?
- (2012) Noora Ottman et al. Frontiers in Cellular and Infection Microbiology
- Appendicectomy as a potential therapy for refractory ulcerative proctitis
- (2011) S. Bageacu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
- (2011) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Treating Clostridium difficile Infection With Fecal Microbiota Transplantation
- (2011) Johan S. Bakken et al. Clinical Gastroenterology and Hepatology
- Modifying the Protease, Antiprotease Pattern by Elafin Overexpression Protects Mice From Colitis
- (2011) Jean–Paul Motta et al. GASTROENTEROLOGY
- Altered Endoplasmic Reticulum Stress Affects Translation in Inactive Colon Tissue From Patients With Ulcerative Colitis
- (2011) Xavier Tréton et al. GASTROENTEROLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
- (2011) L. Marelli et al. GUT
- New therapies for inflammatory bowel disease: from the bench to the bedside
- (2011) Silvio Danese GUT
- Local appendiceal dysbiosis: the missing link between the appendix and ulcerative colitis?
- (2011) X Roblin et al. GUT
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Smoking therapy may be an extreme cure in exsmokers with steroid-dependent and resistant ulcerative colitis
- (2011) Mario Cottone et al. INFLAMMATORY BOWEL DISEASES
- Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we?
- (2011) Stacy A. Kahn et al. INFLAMMATORY BOWEL DISEASES
- Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts
- (2011) Fernando Magro et al. INFLAMMATORY BOWEL DISEASES
- Nanomedicine: Application Areas and Development Prospects
- (2011) Houria Boulaiz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Hypoxia and Inflammation
- (2011) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
- (2011) J. T. Dudley et al. Science Translational Medicine
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
- (2011) M. Sirota et al. Science Translational Medicine
- Topical Rosiglitazone Treatment Improves Ulcerative Colitis by Restoring Peroxisome Proliferator-Activated Receptor-γ Activity
- (2010) Gitte Pedersen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective Study
- (2010) Prévost Jantchou et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
- (2010) Asher Kornbluth et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease
- (2010) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Endoplasmic reticulum stress: implications for inflammatory bowel disease pathogenesis
- (2010) Arthur Kaser et al. CURRENT OPINION IN GASTROENTEROLOGY
- Bile salts and cholestasis
- (2010) Lucas Maillette de Buy Wenniger et al. DIGESTIVE AND LIVER DISEASE
- Ulcerative colitis in the Tuzla region of Bosnia and Herzegovina between 1995 and 2006: epidemiological and clinical characteristics
- (2010) Nermin N. Salkic et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- 1008 No Increase in JC Viremia, Lymphocyte Count, or Circulating CD34+ Hematopoietic Progenitor Cells After Treatment With Vedolizumab, a Humanized Monoclonal Antibody to α4β7 Integrin
- (2010) Asit Parikh et al. GASTROENTEROLOGY
- Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus
- (2010) Seth T. Walk et al. INFLAMMATORY BOWEL DISEASES
- Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis
- (2010) Jesús K. Yamamoto-Furusho et al. INFLAMMATORY BOWEL DISEASES
- Lipid Based Therapy for Ulcerative Colitis—Modulation of Intestinal Mucus Membrane Phospholipids as a Tool to Influence Inflammation
- (2010) Hannah Schneider et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines
- (2010) D. Scott Wilson et al. NATURE MATERIALS
- Revisiting the Rosiglitazone Story — Lessons Learned
- (2010) Clifford J. Rosen NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease
- (2010) Magali Fasseu et al. PLoS One
- Review: Anti-adhesion molecule therapy for inflammatory bowel disease
- (2010) Subrata Ghosh et al. Therapeutic Advances in Gastroenterology
- Appendicectomy as a Therapy for Ulcerative Proctitis
- (2009) Terry Dorcen Bolin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-γ-STAT-1 pathway in macrophages
- (2009) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Gastrointestinal microbiology enters the metagenomics era
- (2009) Daniel N Frank et al. CURRENT OPINION IN GASTROENTEROLOGY
- Hepatocyte nuclear factor 4α regulation of bile acid and drug metabolism
- (2009) John YL Chiang Expert Opinion on Drug Metabolism & Toxicology
- Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum
- (2009) A. Swidsinski et al. GUT
- Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis
- (2009) Annika Braun et al. INFLAMMATORY BOWEL DISEASES
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
- (2008) Arthur Kaser et al. CELL
- Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis
- (2008) Y. Motomura et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- T1144 Results of a Long-Term Follow-Up Treatment with Delayed Release Phosphatidylcholine in Chronic-Active Ulcerative Colitis
- (2008) Max Karner et al. GASTROENTEROLOGY
- Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial
- (2008) James D. Lewis et al. GASTROENTEROLOGY
- Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease
- (2008) M D Bhavsar et al. GENE THERAPY
- Combined defects in epithelial and immunoregulatory factors exacerbate the pathogenesis of inflammation: mucin 2-interleukin 10-deficient mice
- (2008) Maria van der Sluis et al. LABORATORY INVESTIGATION
- Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
- (2008) Inger Camilla Solberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- How expensive is inflammatory bowel disease? A critical analysis
- (2008) Selwyn Odes WORLD JOURNAL OF GASTROENTEROLOGY
- A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis
- (2008) Hong-Liang Liang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis
- (2008) Chad K Heazlewood et al. PLOS MEDICINE
- Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family
- (2007) Thierry Moreau et al. BIOCHIMIE
- Endoplasmic reticulum stress induced by aqueous extracts of cigarette smoke in 3T3 cells activates the unfolded-protein-response-dependent PERK pathway of cell survival
- (2007) Arnd Hengstermann et al. FREE RADICAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started